gga-mir-130a: gga-mir-130a is a microRNA that has been found to be downregulated in an MDV-infected spleen, and it inhibits the proliferation and migration of MSB-1 cells by targeting homeobox A3 (HOXA3) and myogenic differentiation (MyoD) family inhibitor domain containing (MDFIC) [PMC6862082]. It has also been shown to inhibit MSB-1 cell proliferation and migration [PMC7587795]. The expression of gga-mir-130a, along with several other miRNAs, has been detected in various studies [PMC3406056]. Furthermore, gga-mir-130a, along with other miRNAs such as gga-miR-221 and gga-miR-222, has been shown to influence the function of mature DCs [PMC4735322]. Quantitative real-time PCR analysis confirmed the expression levels of gga-mir-130a in different studies [PMC4735322]. Functional studies have revealed that gga-mir-130a inhibits MDV-transformed lymphoid cells proliferation and migration by targeting HoxA3 [PMC6663980]. In a study on fat broiler lines, gga-mir-130a was found to be lowly expressed [PMC4326283]. Both gga-mir-130a and gga-miR-103 have been shown to inhibit the proliferation of MSB1 cells [PMC5484716]. Specifically, gga-mir-130a targets HOXA3 and MDFIC while gga-miR103 targets CCNE1 and TFDP2 [PMC5484716].